Hana Pharm Co., Ltd. (KRX:293480)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,230
-30 (-0.27%)
Apr 16, 2025, 3:30 PM KST
-15.31%
Market Cap 200.12B
Revenue (ttm) 139.33B
Net Income (ttm) 24.30B
Shares Out 17.77M
EPS (ttm) 2,243.00
PE Ratio 5.02
Forward PE n/a
Dividend 510.00 (4.54%)
Ex-Dividend Date Dec 27, 2024
Volume 12,378
Average Volume 35,708
Open 11,230
Previous Close 11,260
Day's Range 11,110 - 11,280
52-Week Range 10,050 - 13,580
Beta 0.45
RSI 63.56
Earnings Date May 15, 2025

About Hana Pharm

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1996
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 293480
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.